International Stem Cell (OTCMKTS:ISCO) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

International Stem Cell Corp. (OTCMKTS:ISCO) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.16 and traded as high as $0.20. International Stem Cell shares last traded at $0.20, with a volume of 66,372 shares.

International Stem Cell Price Performance

The company’s fifty day moving average price is $0.17 and its 200-day moving average price is $0.16. The stock has a market capitalization of $1.60 million, a PE ratio of -3.33 and a beta of -0.01.

International Stem Cell (OTCMKTS:ISCO) last posted its quarterly earnings results on Thursday, May 14th. The biotechnology company reported ($0.03) earnings per share for the quarter. The company had revenue of $2.32 million during the quarter.

About International Stem Cell

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.